Details

NameSymbolSector
SHUKRA PHARMACEUTICALS LIMITEDSHUKRAPHARPharmaceuticals
Open
28.77
High
31.79
Low
28.77
Close
31.79
Volume
923714
Exchange
bse
Time
13-May-2026

Outlook

Score:  

5.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Shukra Pharmaceuticals is  
Marubozu
Estimated Stoploss of Shukra Pharmaceuticals is ₹  
28.77
Shukra Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Shukra Pharmaceuticals has chances of  
Continuationℹ
 of the current trend. 

Trend

Shukra Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Shukra Pharmaceuticals is  
Downℹ
 by  

7.43

%. 
Target
Buy @ 

27.63

Sell @ 

45.21

Current @ 

31.79

Volume

The trades of Shukra Pharmaceuticals have been in  
Immenseℹ
 volume. 
The volume trades for Shukra Pharmaceuticals are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Shukra Pharmaceuticals is  

Up

 by  

151.4

% 

Valuation

The current market price of Shukra Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 86cr and total assets worth ₹ 86cr, the balance sheet of Shukra Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Shukra Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Downℹ
 by  

66.67

%. 

(*Mar 2025)

58.33% i.e. ₹ 7cr earned in operatingℹ
8.33% i.e. ₹ 1cr spent in investingℹ
33.33% i.e. ₹ 4cr spent in financingℹ
0% in otherℹ
Shukra Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 6cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

27.78% i.e. ₹ 5cr spent in operatingℹ
5.56% i.e. ₹ 1cr spent in investingℹ
66.67% i.e. ₹ 12cr earned in financingℹ
0% in otherℹ
Income
The income of Shukra Pharmaceuticals is  

₹ 7cr

 and  

Profit

 is :  

₹ 2cr

(*Sep 2025)

Shukra Pharmaceuticals Profit is up by:  

100

% and Income is Up by:  

16.67

% 

(*Sep 2025)

The income of Shukra Pharmaceuticals is  

₹ 6cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Shukra Pharmaceuticals Profit is down by:  

80

% and Income is Down by:  

57.14

% 

(*Jun 2025)

The income of Shukra Pharmaceuticals is  

₹ 14cr

 and  

Profit

 is :  

₹ 5cr

(*Mar 2025)

Shukra Pharmaceuticals Profit is up by:  

66.67

% and Income is Up by:  

27.27

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.